Table 3.
Polyethylene Glycol or Common Injectable Medication Containing Polyethylene Glycol Allergy Among Patients With an Appointment to a Primary Care Provider Participating in Canadian Primary Care Sentinel Surveillance Network Between January 1, 2016, and December 31, 2018
| N = 1,055,677 | |
|---|---|
| Medication | Frequency |
| Macrogol (A06AD15) | 10 |
| Methylprednisolone acetate (H02AB04) | 19 |
| Methoxy polyethylene glycol epoetin beta (Micera) (B03XA03) | 0 |
| Pegfilgrastim (Neulasta) L03AA13 | 0 |
| Medroxyprogesterone acetate (Depo-Provera) (G03DA02, G03AC06, G03AA08, G03AA17, G03FA12, L02AB02) | 56 |
| Brilliant Blue G Ophthalmic Solution (TissueBlue)—key word search | 0 |
| Sulfur hexafluoride (Lumason) (V08DA05) | 45 |
| Biomatoprost implant (Durysta)—key word search | 0 |
| Trastuzumab (L01XC03, L01XC41, L01XC14) | 2 |
| Rilonacept (Arcalyst) (L04AC04) | 0 |
| Perflutren lipid microsphere (Definity) (V08DA01, V08DA04) | 3 |
| Total | 135 |